The molecules mimic a gene variant that protects against Crohn’s, demonstrating a roadmap for using genetics to develop therapies for inflammatory bowel disease and other chronic inflammatory disorders.
Whitehead and Ó³»´«Ã½ scientists have developed a gene-silencing tool that could pave the way for a new class of genetic approaches to treat certain diseases.